Our Products
Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More
Research & Development
We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More
AMAG Corporate Principles
Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More
News
AMAG PHARMACEUTICALS ANNOUNCES THE PUBLICATION OF THE PHASE 3 VYLEESI™...
AMAG PHARMACEUTICALS ANNOUNCES THE PUBLICATION OF THE PHASE 3 VYLEESI™ (BREMELANOTIDE INJECTION) DATA IN Obstetrics & Gynecology
The RECONNECT Studies Demonstrated a Clinically Meaningful and Statistically Significant Improvement MoreAMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
Paul Fonteyne and David Johnson Join Board of Directors MoreWorking at AMAG
"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."
David Knauss
Senior Manager, Regulatory Affairs & Medical Writing
